https://www.zacks.com/stock/news/2205957/walgreens-wba-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2205957
Jan 04, 2024 - Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended November 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:4243479856250449967
0
https://seekingalpha.com/article/4661168-walgreens-boots-alliance-inc-wba-q1-2024-earnings-call-transcript?source=feed_sector_transcripts
Jan 04, 2024 - Walgreens Boots Alliance, Inc. (NASDAQ:NASDAQ:WBA) Q1 2024 Earnings Conference Call January 4, 2024 8:30 AM ETCompany ParticipantsTiffany Kanaga - Vice...
0
sa:3454899904815432301
0
https://www.zacks.com/stock/news/2204345/conagra-lamb-weston-walgreens-boots-alliance-and-constellation-brands-are-part-of-zacks-earnings-preview?cid=CS-ZC-FT-press_releases-2204345
Jan 02, 2024 - Conagra, Lamb Weston, Walgreens Boots Alliance and Constellation Brands are highlights of Zacks Earnings Preview article.
zc:-830333458605310061
0
https://www.zacks.com/stock/news/2203757/exploring-analyst-estimates-for-walgreens-wba-q1-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2203757
Dec 29, 2023 - Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended November 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:-8297624337652200819
0
https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001
Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
0
fool:-8481294172515244912
0
https://www.zacks.com/stock/news/2203363/walgreens-boots-alliance-wba-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2203363
Dec 28, 2023 - In the latest trading session, Walgreens Boots Alliance (WBA) closed at $26.60, marking a -0.15% move from the previous day.
zc:5296841544990947231
0
https://www.zacks.com/stock/news/2200407/can-dogs-of-the-dow-etfs-snap-losing-trend-in-2024?cid=CS-ZC-FT-etf_news_and_commentary-2200407
Dec 20, 2023 - The Dogs of the Dow underperformed the broader market in 2023. However, with the Fed likely to cut rates in 2024, can these dividend dogs roar next year?
zc:-3706222945078906889
0
https://www.zacks.com/stock/news/2199637/walgreens-boots-alliance-wba-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2199637
Dec 18, 2023 - Walgreens Boots Alliance (WBA) closed the most recent trading day at $24.98, moving -0.87% from the previous trading session.
zc:-323641410752461545
0
https://www.zacks.com/stock/news/2196426/walgreens-boots-alliance-wba-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2196426
Dec 11, 2023 - In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $23, indicating a -0.69% shift from the previous trading day.
zc:6103673919168533412
0
https://www.zacks.com/stock/news/2196004/walgreens-wba-alliancerx-pharmacy-will-now-distribute-xdemvy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196004
Dec 11, 2023 - Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
zc:-4086703999000168526
0